sc13g


	OMB APPROVAL
	OMB Number: 3235-0145
	Expires: February 28, 2009
	Estimated average burden hours per response...10.4

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. ___)*

Hansen Medical, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

411307 10 1

(CUSIP Number)

December 31, 2006

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)

o Rule 13d-1(c)

þ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No.		411307 10 1		Page	2	of		4


1	NAMES OF REPORTING PERSONS: Frederic H. Moll, M.D.

	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
	(a) o
	(b) þ

3	SEC USE ONLY:



4	CITIZENSHIP OR PLACE OF ORGANIZATION:

	USA

		5	SOLE VOTING POWER:

NUMBER OF			1,446,996

SHARES		6	SHARED VOTING POWER:
BENEFICIALLY
OWNED BY			None

EACH		7	SOLE DISPOSITIVE POWER:
REPORTING
PERSON			1,446,996

WITH:		8	SHARED DISPOSITIVE POWER:

			None

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

	1,446,996

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):

	o

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):

	6.73%

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

	IN


				Page	3	of		4

Item 1.

	(a)		Name of Issuer

			Hansen Medical, Inc.

	(b)		Address of Issuer’s Principal Executive Offices

			380 North Bernardo Avenue

			Mountain View, CA 94043

Item 2.

	(a)		Name of Person Filing

			Frederic H. Moll, M.D.

	(b)		Address of Principal Business Office or, if none, Residence

			c/o Hansen Medical, Inc.

			380 North Bernardo Avenue

			Mountain View, CA 94043

	(c)		Citizenship

			USA

	(d)		Title of Class of Securities

			Common Stock

	(e)		CUSIP Number

			411307 10 1

Item 3.		If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

		Not applicable.

Item 4.		Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

	(a)		Amount Beneficially Owned:

			1,446,996

	(b)		Percent of Class:

			6.73%

	(c)		Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote


				Page	4	of		4

			1,446,996

	(ii)		Shared power to vote or to direct the vote

			-0-

	(iii)		Sole power to dispose or to direct the disposition of

			1,446,996

	(iv)		Shared power to dispose or to direct the disposition of

			-0-

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

Item 6.		Ownership of More than Five Percent on Behalf of Another Person

		Not applicable.

Item 7.		Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

		Not applicable

Item 8.		Identification and Classification of Members of the Group

		Not applicable.

Item 9.		Notice of Dissolution of a Group

		Not applicable.

Item 10.		Certification

		Not applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


		February 13, 2007

		Date

		/s/ Frederic H. Moll, M.D.

		Signature

		Frederic H. Moll, M.D.

		Name/Title